Genetic variations of the methylene tetrahydrofolate reductase (MTHFR) enzyme -an enzyme essential in nucleotide synthesis and DNA methylation pathways- have been previously found to confer increased risk for both autoimmune disorders17 and NHL development18–21. Here, MTHFR is linked to non-Hodgkin lymphoma.